Miracle Mile Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.67M | Sell |
13,205
-1,642
| -11% | -$208K | 0.03% | 273 |
|
2025
Q1 | $1.9M | Sell |
14,847
-6,628
| -31% | -$848K | 0.04% | 223 |
|
2024
Q4 | $2.84M | Buy |
21,475
+4,782
| +29% | +$632K | 0.06% | 181 |
|
2024
Q3 | $2.43M | Sell |
16,693
-964
| -5% | -$140K | 0.06% | 169 |
|
2024
Q2 | $2.42M | Sell |
17,657
-7,197
| -29% | -$988K | 0.06% | 168 |
|
2024
Q1 | $3.41M | Buy |
24,854
+308
| +1% | +$42.3K | 0.09% | 143 |
|
2023
Q4 | $3.33M | Sell |
24,546
-300,787
| -92% | -$40.9M | 0.09% | 133 |
|
2023
Q3 | $39.8M | Buy |
325,333
+1,399
| +0.4% | +$171K | 1.23% | 25 |
|
2023
Q2 | $41.1M | Buy |
323,934
+20,653
| +7% | +$2.62M | 1.25% | 24 |
|
2023
Q1 | $39.2M | Buy |
303,281
+12,095
| +4% | +$1.56M | 1.27% | 18 |
|
2022
Q4 | $38.2M | Buy |
291,186
+257,089
| +754% | +$33.8M | 1.31% | 19 |
|
2022
Q3 | $3.99M | Buy |
34,097
+7,790
| +30% | +$911K | 0.19% | 81 |
|
2022
Q2 | $3.1M | Buy |
26,307
+17,572
| +201% | +$2.07M | 0.15% | 116 |
|
2022
Q1 | $1.14M | Buy |
+8,735
| New | +$1.14M | 0.05% | 220 |
|
2020
Q3 | – | Sell |
-1,610
| Closed | -$220K | – | 374 |
|
2020
Q2 | $220K | Buy |
+1,610
| New | +$220K | 0.02% | 284 |
|
2019
Q2 | – | Sell |
-1,790
| Closed | -$200K | – | 272 |
|
2019
Q1 | $200K | Buy |
+1,790
| New | +$200K | 0.02% | 252 |
|